BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 17201906)

  • 1. Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers.
    Blumenthal RD; Leon E; Hansen HJ; Goldenberg DM
    BMC Cancer; 2007 Jan; 7():2. PubMed ID: 17201906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen).
    Blumenthal RD; Hansen HJ; Goldenberg DM
    Cancer Res; 2005 Oct; 65(19):8809-17. PubMed ID: 16204051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in colorectal cancer.
    Kim KS; Kim JT; Lee SJ; Kang MA; Choe IS; Kang YH; Kim SY; Yeom YI; Lee YH; Kim JH; Kim KH; Kim CN; Kim JW; Nam MS; Lee HG
    Clin Chim Acta; 2013 Jan; 415():12-9. PubMed ID: 22975528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoembryonic antigen-related cell adhesion molecule 1 is expressed and as a function histotype in ovarian tumors.
    Li N; Yang JY; Wang XY; Wang HT; Guan BX; Zhou CJ
    Ann Diagn Pathol; 2016 Feb; 20():7-12. PubMed ID: 26653024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CEACAM6 as detected by the AP11 antibody is a marker notable for mucin-producing adenocarcinomas.
    Lee OJ; Son SM; Hong KP; Lee YM; Kim MY; Choi JW; Lee SJ; Song YJ; Kim HS; Kim WJ; Shin SO; Song HG
    Virchows Arch; 2015 Feb; 466(2):151-9. PubMed ID: 25427744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CEACAM5 and CEACAM6 are major target genes for Smad3-mediated TGF-beta signaling.
    Han SU; Kwak TH; Her KH; Cho YH; Choi C; Lee HJ; Hong S; Park YS; Kim YS; Kim TA; Kim SJ
    Oncogene; 2008 Jan; 27(5):675-83. PubMed ID: 17653079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CEACAM6 induces epithelial-mesenchymal transition and mediates invasion and metastasis in pancreatic cancer.
    Chen J; Li Q; An Y; Lv N; Xue X; Wei J; Jiang K; Wu J; Gao W; Qian Z; Dai C; Xu Z; Miao Y
    Int J Oncol; 2013 Sep; 43(3):877-85. PubMed ID: 23857344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis.
    Beauchemin N; Arabzadeh A
    Cancer Metastasis Rev; 2013 Dec; 32(3-4):643-71. PubMed ID: 23903773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiling of CEACAM6 associated with the tumorigenesis and progression in gastric adenocarcinoma.
    Deng X; Liu P; Zhao Y; Wang Q
    Genet Mol Res; 2014 Sep; 13(3):7686-97. PubMed ID: 25299082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation.
    Ilantzis C; DeMarte L; Screaton RA; Stanners CP
    Neoplasia; 2002; 4(2):151-63. PubMed ID: 11896570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas.
    Schölzel S; Zimmermann W; Schwarzkopf G; Grunert F; Rogaczewski B; Thompson J
    Am J Pathol; 2000 Feb; 156(2):595-605. PubMed ID: 10666389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 trans-signaling increases the expression of carcinoembryonic antigen-related cell adhesion molecules 5 and 6 in colorectal cancer cells.
    Holmer R; Wätzig GH; Tiwari S; Rose-John S; Kalthoff H
    BMC Cancer; 2015 Dec; 15():975. PubMed ID: 26673628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CEACAM6 promotes tumor migration, invasion, and metastasis in gastric cancer.
    Zhang Y; Zang M; Li J; Ji J; Zhang J; Liu X; Qu Y; Su L; Li C; Yu Y; Zhu Z; Liu B; Yan M
    Acta Biochim Biophys Sin (Shanghai); 2014 Apr; 46(4):283-90. PubMed ID: 24492534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of CEACAM6 in borderline and invasive mucinous ovarian neoplasms.
    Litkouhi B; Litkouhi B; Fleming E; Welch WR; Berkowitz RS; Birrer MJ; Mok SC
    Gynecol Oncol; 2008 May; 109(2):234-9. PubMed ID: 18331757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic screen of sixty-eight colorectal cancer cell lines identifies CEACAM6 and CEACAM5 as markers of acid resistance.
    Michl J; White B; Monterisi S; Bodmer WF; Swietach P
    Proc Natl Acad Sci U S A; 2024 Mar; 121(13):e2319055121. PubMed ID: 38502695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) promotes EGF receptor signaling of oral squamous cell carcinoma metastasis via the complex N-glycosylation.
    Chiang WF; Cheng TM; Chang CC; Pan SH; Changou CA; Chang TH; Lee KH; Wu SY; Chen YF; Chuang KH; Shieh DB; Chen YL; Tu CC; Tsui WL; Wu MH
    Oncogene; 2018 Jan; 37(1):116-127. PubMed ID: 28892050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1, 5 and 6 as biomarkers in pancreatic cancer.
    Gebauer F; Wicklein D; Horst J; Sundermann P; Maar H; Streichert T; Tachezy M; Izbicki JR; Bockhorn M; Schumacher U
    PLoS One; 2014; 9(11):e113023. PubMed ID: 25409014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in breast cancers.
    Tsang JY; Kwok YK; Chan KW; Ni YB; Chow WN; Lau KF; Shao MM; Chan SK; Tan PH; Tse GM
    Breast Cancer Res Treat; 2013 Nov; 142(2):311-22. PubMed ID: 24186057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoembryonic antigen cell adhesion molecule 6 predicts breast cancer recurrence following adjuvant tamoxifen.
    Maraqa L; Cummings M; Peter MB; Shaaban AM; Horgan K; Hanby AM; Speirs V
    Clin Cancer Res; 2008 Jan; 14(2):405-11. PubMed ID: 18223215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance.
    Jantscheff P; Terracciano L; Lowy A; Glatz-Krieger K; Grunert F; Micheel B; Brümmer J; Laffer U; Metzger U; Herrmann R; Rochlitz C
    J Clin Oncol; 2003 Oct; 21(19):3638-46. PubMed ID: 14512395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.